India's automobile dealerships are watching the ongoing Middle East conflict closely, warning that its ripple effects on fuel prices and auto parts supply chains could intensify in the months ahead — even as the country's retail vehicle sales hit an all-time high for the month of April. Sai Giridhar, vice-president of the Federation of Automobile Dealers Associations (Fada), told reporters on Tuesday that while disruptions have so far remained contained in the world's third-largest car market, persistent regional instability could begin squeezing auto component supplies before long. "There have been some instances of supply getting disrupted, particularly in parts shipments coming from Europe, mainly in the after-market and service side," Giridhar noted. He added that the downstream effects could linger for several months even after the conflict eventually winds down. His remarks echo broader anxieties within India's economic community that a prolonged conflict involving Iran — and the resulting energy price shock — could dampen growth momentum and stoke inflation. Leading automaker Maruti Suzuki has already signaled it may be forced to pass rising commodity costs on to consumers through price hikes. Despite these headwinds, India's auto sector has been riding a wave of strong performance in recent months. A combination of tax relief introduced last September, more accessible financing conditions, and surging demand from smaller towns and rural markets has kept dealership floors busy. However, that momentum may face pressure going forward.

New Delhi, May 5 — India and Japan have reaffirmed their commitment to building stronger, more resilient healthcare systems through a landmark bilateral meeting held in the national capital on Tuesday. The third Joint Committee Meeting (JCM) on Healthcare brought together senior officials and ministers from both nations to map out a shared vision for the future of health cooperation, covering areas ranging from pharmaceutical supply chains and digital health infrastructure to medical workforce exchange and innovation. The meeting was co-chaired by Union Minister of Health and Family Welfare Jagat Prakash Nadda and Japan's Minister in charge of Healthcare Policy Kimi Onoda. The discussions underscored the deepening strategic partnership between Asia's two largest democracies in the health sector and reflected a mutual recognition that robust healthcare systems are foundational to long-term national resilience. Opening the session, Minister Nadda emphasized that the meeting was a natural extension of the shared commitment both nations have demonstrated toward healthcare cooperation. He pointed out that the India-Japan collaboration in the health domain is underpinned by a formal Memorandum of Cooperation in Healthcare and Wellness, which provides an institutional framework for advancing joint priorities. Nadda noted that the guiding philosophy of 'Sabka Saath, Sabka Vikas' — meaning inclusive development for all — continues to shape India's approach to both domestic and international health partnerships. He described the JCM as a critical platform for translating that shared vision into concrete, actionable outcomes. For her part, Minister Onoda reaffirmed Japan's commitment to expanding its engagement with India in healthcare, particularly through innovation, cutting-edge technology, and collaborative research. She expressed a clear readiness to push bilateral cooperation into deeper territory, signaling that Japan views India not just as a partner in health diplomacy, but as a key collaborator in shaping the future of global health systems. Welcoming the Japanese delegation separately, Union Health Secretary Punya Salila Srivastava struck a tone of warmth and optimism, describing the India-Japan partnership as one built on mutual respect, trust, and a common vision for what the future of healthcare should look like. Her remarks set a cooperative and forward-looking tone for the technical discussions that followed. The bulk of the JCM was devoted to in-depth discussions across four major priority areas — non-communicable diseases, supply chain resilience, digital health, and human resource development — each of which carries significant implications for how both countries manage healthcare delivery in the years ahead.  

Tata Power Renewable Energy Limited has unveiled an ambitious plan to invest up to ₹6,500 crore in building a photovoltaic ingot and wafer manufacturing facility with a total installed capacity of 10 GW. The proposal has received formal approval from the company's board and represents a significant step in its strategy to expand upstream into the solar manufacturing value chain. The move signals Tata Power's entry into one of the most critical segments of the solar supply chain — the production of ingots and wafers, which serve as essential raw inputs for the manufacture of solar cells and modules. This vertical expansion aligns closely with India's broader national push to deepen domestic solar manufacturing capabilities under the Approved List of Models and Manufacturers (ALMM) framework. The ALMM framework is expected to be extended to cover wafers by 2028, subject to sufficient capacity development and localisation conditions being met by industry players. Phased Development and Capacity Rollout The planned facility will be developed in two distinct phases, each with a capacity of 5 GW, ultimately scaling up to a combined total of 10 GW. This phased approach allows the company to manage capital deployment prudently while progressively building out production infrastructure. The output from the facility is expected to serve both captive internal demand — supporting Tata Power's own solar project pipeline — as well as external sales to the broader domestic market. At the heart of this initiative is a drive toward backward integration. By producing ingots and wafers locally, Tata Power aims to reduce its dependence on imported solar components, particularly those sourced from China, which continues to hold a dominant position in global solar supply chains.

Supply chain disruptions and surging packaging costs tied to elevated crude oil prices are squeezing local competitors in key emerging markets like India, and Unilever sees this as a window of opportunity to deepen its foothold and accelerate volume growth. During the company's latest earnings call, Chief Executive Officer Fernando Fernández highlighted that smaller, local players — particularly across India and Southeast Asia — are facing mounting operational constraints. These pressures, he noted, are creating conditions that could support Unilever's volume expansion and make future pricing actions more feasible to implement. Fernández underscored that the company continues to identify and capitalize on opportunities emerging from global supply limitations, even as its own multipolar supply chain remains robust and adaptable. The results from India tell a compelling story. In the first quarter of 2026, Unilever achieved its highest-ever market share in laundry powders within the Indian market. The company is also making deliberate inroads into the fast-growing liquid detergent segment, signaling an intent to capture shifting consumer preferences as households increasingly move toward premium and convenient product formats. Chief Financial Officer Srinivas Phatak painted a confident picture of Hindustan Unilever Ltd's performance, describing it as being of a very high order. HUL registered 6 per cent volume growth during the March quarter, a figure that reflects both strong consumer demand and the company's strategic execution on the ground. Phatak acknowledged that inflationary pressures have not disappeared. Imported crude oil and currency fluctuations continue to weigh on input costs. However, he pointed out that certain categories, particularly home care, tend to benefit when inflation rises — a somewhat counterintuitive dynamic that works in Unilever's favour in this environment. He also highlighted that HUL's diverse and wide-ranging product portfolio enables the company to serve consumers across multiple price points, giving it a structural advantage over local rivals who are simultaneously grappling with supply bottlenecks and constrained cash flows. Describing the current situation as a unique opportunity, Phatak expressed strong confidence that India will continue to be a key engine of growth for Unilever.